Background Weight gain is often considered a side effect of combination hormonal
contraceptives, and many women and clinicians believe that an association exists. Concern …

Background Concern about estrogen‐related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …

Objective: To compare the efficacy of a new low-dose oral contraceptive pill (OCP)
formulation with placebo in reducing symptoms of premenstrual dysphoric disorder …

The introduction of the birth control pill as an effective, coitally-independent method of
contraception was a public health milestone of the last century. Over time, combined oral …

This open-label, multicenter study evaluated the efficacy, safety, and cycle control of Yasmin,
a new low-dose, monophasic oral contraceptive containing the unique progestogen …

Estrogen content represents a tradeoff between cycle control and side effects, but few direct
comparisons of 20 and 30/35 μg preparations are available. To address this issue, we …

The aim of this open-label, multicenter, noncomparative study was to determine the efficacy,
safety and bleeding profile of a new low-dose, monophasic combined oral contraceptive …

Most women have used at least 1 method of contraception during their reproductive years,
with the majority favoring combined oral contraceptives. Women are often concerned about …

Approximately half (51%) of the 6.6 million pregnancies in the US each year are unintended
and half of those pregnancies (54%) occur among women not using contraception. Many …

OBJECTIVE: Many women and clinicians believe that combination estrogen–progestin
contraceptive use can lead to weight gain. This concern can deter women from starting …